HomeSUPN • NASDAQ
add
Supernus Pharmaceuticals Inc
Previous close
$54.56
Day range
$54.16 - $56.49
Year range
$29.16 - $59.68
Market cap
3.20B USD
Avg Volume
847.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 211.57M | 21.48% |
Operating expense | 144.82M | 12.70% |
Net income | -4.10M | -126.78% |
Net profit margin | -1.94 | -122.05% |
Earnings per share | 0.88 | 60.88% |
EBITDA | 40.73M | 6.05% |
Effective tax rate | -114.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 308.67M | -31.95% |
Total assets | 1.45B | 6.18% |
Total liabilities | 390.93M | 17.63% |
Total equity | 1.06B | — |
Shares outstanding | 57.46M | — |
Price to book | 2.95 | — |
Return on assets | 2.77% | — |
Return on capital | 3.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.10M | -126.78% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2005
Headquarters
Website
Employees
674
